Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00718328 · ClinicalTrials.gov registry record · Phase 2
Simvastatin For Intracerebral Hemorrhage Study
A Phase 2 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00718328: Clinical Trial Phase 2 study, sponsored by Johns Hopkins University.
NCT00718328 is a Phase 2 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00718328, a Phase 2 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Study Objective: To analyze if statins are effective in ameliorating perihematomal edema evolution thereby reducing mortality and improving functional outcomes following spontaneous intracerebral hemorrhage (ICH).
Primary Outcome
Solitary patient lost to follow up (out of state)
Interventions
- DRUG Placebo
- DRUG Simvastatin 80 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Why NCT00718328 stopped before completion
NCT00718328 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00718328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00718328 about?
NCT00718328 is a clinical study titled "Simvastatin For Intracerebral Hemorrhage Study". Study Objective: To analyze if statins are effective in ameliorating perihematomal edema evolution thereby reducing mortality and improving functional outcomes following spontaneous intracerebral hemorrhage (ICH).
What is the current status of trial NCT00718328?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2008-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00718328?
The interventions under investigation include: Placebo (DRUG), Simvastatin 80 mg (DRUG).
Who is sponsoring clinical trial NCT00718328?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00718328's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia